Lightcalls.com
 

As in the greatest degree people fa...

As in the greatest degree people familiar with the natural nutritions industry are aware, since 1994 ephedra returnss have been scrupulously monitored for safety since reports of adverse drifts associated with this ancient herb were reported to the forage and Drug Administration

NNFA takes a stand

In answer to these reports, the National Nutritional provisionss Association (NNFA) and other industry trade associations sought the guidance of various industry herbal and legal master-hands to help develop a joint position statement forward the safe and appropriate marketing and use of Ephedra-containing products

Ephedra Update reviews

dosages

Regarding dosage for dietary complement use, "An Ephedra Update," dated September 30 1996 issued by way of the NNFA states: "NNFA's medical consultant, Dr Michael Davidson, reviewed many of the [FDA] reports and conclud that dosages of 12 to 15 mg [ephedrine alkaloids] by dose, four times per day is reasonable for dietary postscript use."

Davidson says in his have a title to statement dated August 27, 1996 that he would commend an active surveillance program with approximately 1000 produce consumers in various product categories to better ascertain the commonness and severity of adverse reactions," and that labels forward Ephedra-containing products should caution against "use from smokers, those taking oral contraceptives, and those with a history of cardiovascular or seizure disorders."



The NNFA update continues, "These quicks who served on FDA's Special Working form into groups on Ephedra, now recommend soft doses, strong cautions, and no claims. They advise this is the barely responsible way to market Ephedra. Taking these ready opinions into account, NNFA will vigorously justify Ephedra as a dietary addition ingredient....

"Ephedra is an herb that must be treated with regard The NNFA will continue to work with its members and maintain a dialogue with State and Federal regulatory authorities to assure the continued availability of legitimate, suitably labeled dietary supplements containing Ephedra."

Ohio lifts ephedra ban

Following the adverse reports onward ephedra-containing substances many states bring forward a ban on them or instituted laws making them available from prescription only. One such state was Ohio. The December 1996 issue of NNFA Today reports that thanks to a bill co-sponsored according to Ohio Rep. Bill Schuck and Sen Susan Dix, the Ohio legislature passed legislation lifting the ban upon ephedra-containing products from being sold in health aliment stores.

through the last several years, before and over all of the afore-described occurrences a number of reputable research laboratories have carried on the outside extensive studies on ma huang (an ephredra-containing product)

During that time scientists have perform the operations indicated ined many methods for improving the safety of ma huang works without sacrificing effectiveness.

A not many important suggestions on the informed

and safe use of ma huang:

*Product containing standardized ma huang extract should clearly state the number of milligrams and the percent of standardization.

*Traditional applications of ma huang do not normally provide for long-term consumption. Neither does the FDA. However, as a commons long-term use of ma huang is permissible in the U unless in this case, as with all provenders no therapeutic claims for the herb are allowed.

*Modern research has established that in a less degree than certain conditions, ma huang may be used for fairly augmented periods of time to stimulate los of visible form [i]or[/i] frame fat by activating brown adipose tissue, the body's gland responsible for burning distant from excess fat. It is inadvisable to use ma huang at itself for this application because effective dosages give rise to unwanted side effects.

Finally, I think we all now know that it is possible to abuse ma huang, and that these issues should not be sold directly to children.

I reliance the above remarks will help you evaluate the appropriateness, safety, and efficacy of ma huang results To the extent that we exercise responsibility in their selection, we will be able to save this valuable herb and fix a precedent for responsible herb regulation in our have industry.

COPYRIGHT 1997 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2004 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.